Pharming
CSL accuses ex-exec, now at Pharming, of stealing trade secrets
Phil Taylor
CSL Behring, hereditary angioedema, Pharming
0 Comment
X
CSL accuses ex-exec, now at Pharming, of stealing trade secrets
https://pharmaphorum.com/news/csl-accuses-ex-exec-now-at-pharming-of-stealing-trade-secrets/
Pharming buys rare disease drug from Novartis for $20m
Richard Staines
Novartis, Pharming, R&D, Rare diseases
0 Comment
X
Pharming buys rare disease drug from Novartis for $20m
https://pharmaphorum.com/news/pharming-buys-rare-disease-drug-from-novartis-for-20m/
R&D/ Views & Analysis/ Views and analysis
Dutch biotech Pharming plans to challenge big pharma in rare diseases
X
Dutch biotech Pharming plans to challenge big pharma in rare diseases
https://pharmaphorum.com/r-d/views-analysis-r-d/pharming-challenge-pharma-rare-diseases/
FDA rejects Pharming’s Ruconest HAE label expansion
Joy Persaud
hereditary angioedema, Pharming, Rare diseases, Shire
0 Comment
X
FDA rejects Pharming’s Ruconest HAE label expansion
https://pharmaphorum.com/news/fda-rejects-pharmings-ruconest-hae-label-expansion/